InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Monday, 02/09/2015 6:39:05 PM

Monday, February 09, 2015 6:39:05 PM

Post# of 403035
Greetings. Uncertain of the level of knowledge here-all I can claim is a desire to learn more about the stock and p53 therapeutics generally. This is based on general interest as a physician and an investor, and a personal interest- my wife's sister has pancreatic CA, a potential p53 target tumor based on her genetic analysis. Came across CTIX and found some stuff on Yahoo and was directed here and will start learning.

Just for starters- Why did you choose CTIX to invest in? How to know if this company really has something special, or if other p53 efforts are better? A quick internet search turns up Aprea in Scandinavia, also in trials, one with AML staring and one with ovarian CA. I need to try to look through the science to understand whether it might be better or not. Aprea is a private company.

Brilacidin- won't it lose out as Daptomycin becomes generic and gets a price cut advantage? Trial suggests slightly better, not loads better, than Daptomycin.

Thanks for any thoughts. I will of course try to catch up on my own, though I wonder about how much some of you may alrey know about these issues.

Sam
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News